the world should have access to therapies that will help them
enjoy a better post-incident quality of life"
Novel Drug Candidates
Infensa has a unique portfolio of peptide drugs that protect neurons and heart muscle cells from ischemic injury
Protection of the Brain
Infensa drugs protect the brain from stroke-induced injury
Protection of the Heart
Infensa drugs protect the heart from injury suffered during a heart attack
Game-Changing Therapies
Infensa will develop game-changing therapies for cardiovascular disorders that kill 15 million people every year
An overview of the opportunity
- First-in-class drugs with addressable worldwide market of tens of millions of patients per year
- Ability of a single drug class to address multiple diseases enables staged clinical development with continuous value creation
- Other potential indications: traumatic head injury, hypoxic brain injury (cerebral palsy), retinal artery thrombosis, kidney artery thrombosis, cardiac and brain surgery, endarterectomy, heart valve replacement
- Key asset protected by patents granted globally
- Outstanding executive team with more than a century combined experience in the biotech sector